“Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation: Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF” (2022) Mediterranean Journal of Hematology and Infectious Diseases, 14(1), p. e2022025. doi:10.4084/MJHID.2022.025.